NCT06888830 2025-06-19
A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour
Shanghai Junshi Bioscience Co., Ltd.
Phase 1/2 Recruiting
Clinical Trials
3 trialsNCT06600022 2025-01-16
Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours.
Sinocelltech Ltd.
Phase 1/2 Recruiting
NCT06304818 2024-03-15
Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB14 in Adult Patients With Advanced Malignant Solid Tumours.
Sinocelltech Ltd.
Phase 1/2 Not yet recruiting